ReShape Lifesciences Inc
|Market Cap (Intraday)||21.98M|
|2yr Forward PE||N/A|
ReShape Lifesciences Inc. Stock, NASDAQ:RSLS
ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShapeCare and Diabetes Bloc-Stim Neuromodulation Device. The company is headquartered in San Clemente, CA.